BioCatalystWatch
OCULWorkspace / OCUL / OverviewCompany library
OCULAR THERAPEUTIX, INC logo

OCULAR THERAPEUTIX, INC

OCULAR THERAPEUTIX, INC (OCUL)

Website

Price
Market cap
Next catalystSOL-R topline in Q1 2028 after key secondary endpoint evaluationAXPAXLI — wet AMD: SOL-1, SOL-R and SOL-X · Phase 3 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

AXPAXLI

VEGFR-1 × VEGFR-2 × VEGFR-3 × PDGFR

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

AXPAXLI

VEGFR-1 × VEGFR-2 × VEGFR-3 × PDGFR

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Other pipelines

AXPAXLI

VEGFR-1 × VEGFR-2 × VEGFR-3 × PDGFR

AXPAXLI

VEGFR-1 × VEGFR-2 × VEGFR-3 × PDGFR

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

Approved / commercial

History / paused

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

OCUL SEC archive